Company / Operating Income
Thermo Fisher Scientific Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$7.7B
FY2025
5-year range
$4.6B / $10.0B
FY2021-FY2025
Trend
+5.6%
vs FY2024
Sector context
#4 of 156
Health Care
What the data says
Among 156 Health Care companies, Thermo Fisher Scientific is in the top 3% for operating income. Operating Income has fluctuated over the past 10 years, ranging from $2.5B in FY2016 to $10.0B in FY2023.
Based on SEC 10-K filings.
$7.7B in FY2025 with a 5-year CAGR of -0.1%. Top quartile in the Health Care sector.
Declined from $10.0B to $7.7B over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -0.2%
- 5-Year CAGR
- -0.1%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 156This company $7.7B Sector average $733.1M
▼
+956.7% above sector average
Key checks
Key Insights
- 5-year CAGR of -0.1%, indicating a declining trend.
- In FY2025, operating income increased 5.6% year-over-year.
- Ranks #4 out of 156 companies in the Health Care sector.
- Peak operating income was recorded in FY2023.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.7B | +5.6% |
| FY2024 | $7.3B | -26.8% |
| FY2023 | $10.0B | +28.7% |
| FY2022 | $7.8B | +69.7% |
| FY2021 | $4.6B | -41.1% |
| FY2020 | $7.8B | +69.7% |
| FY2019 | $4.6B | +21.4% |
| FY2018 | $3.8B | +27.8% |
| FY2017 | $3.0B | +20.4% |
| FY2016 | $2.5B | +5.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026